TEL AVIV, Israel, March 6, 2011 /PRNewswire-FirstCall/ -- Elbit Imaging
Ltd. (NASDAQ: EMITF) ("Elbit") announced today that Midroog Ltd., an
affiliate of Moody's Investors Services, has ratified its rating of
"A2/Negative", on a local scale, for all of Elbit's outstanding notes. In
addition, the above mentioned credit rating was also ratified for expansion
of existing debt of par value NIS 120 million. Elbit is examining the
possibility of a future debt offering, but there is no certainty that any
such debt offering will be executed.
Any future debt offering, if made, will be executed in Israel to
residents of Israel only. Any debt instruments that may be offered will not
be registered under the U.S. Securities Act of 1933, as amended, and may not
be offered or sold in the United States absent registration or an applicable
exemption from U.S. registration requirements.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following principal fields of
business: (i) Commercial and Entertainment Centers - Initiation, construction
and sale of shopping and entertainment centers and other mixed-use real
property projects, predominantly in the retail sector, located in Central and
Eastern Europe and in India; (ii) U.S. Real Property - Investment in
commercial real property in the United States; (iii) Hotels - Hotel operation
and management, primarily in major European cities; (iv) Medical Industries -
(a) research and development, production and marketing of magnetic resonance
imaging guided focused ultrasound treatment equipment and (b) development of
stem cell population expansion technologies and stem cell therapy products
for transplantation and regenerative medicine; (v) Residential Projects -
Initiation, construction and sale of residential projects and other mixed-use
real property projects, predominately residential, located primarily in India
and in Eastern Europe; (vi) Fashion Apparel - distribution and marketing of
fashion apparel and accessories in Israel; and (vii) Other Activities - (a)
venture capital investments; and (b) investments in hospitals and farm and
dairy plants in India.
Any forward-looking statements in our releases include statements
regarding the intent, belief or current expectations of Elbit Imaging Ltd.
and our management about our business, financial condition, results of
operations, and its relationship with its employees and the condition of our
properties. Words such as "believe," "expect," "intend," "estimate" and
similar expressions are intended to identify forward-looking statements but
are not the exclusive means of identifying such statements. Actual results
may differ materially from those projected, expressed or implied in the
forward-looking statements as a result of various factors including, without
limitation, the factors set forth in our filings with the Securities and
Exchange Commission including, without limitation, Item 3.D of our annual
report on Form 20-F for the fiscal year ended December 31, 2009, under the
caption "Risk Factors." In addition, a potential offering would be subject to
risks facing any public offering, including without limitation, general
economic conditions, the conditions of the capital markets, the interest
level of investment banks and investors in the offering and the performance
of our businesses. Any forward-looking statements contained in our releases
speak only as of the date of such release, and we caution existing and
prospective investors not to place undue reliance on such statements. Such
forward-looking statements do not purport to be predictions of future events
or circumstances, and therefore, there can be no assurance that any forward-
looking statement contained our releases will prove to be accurate. We
undertake no obligation to update or revise any forward-looking statements.
For Further Information:
Company Contact:
Dudi Machluf
Chief Executive Officer (Co-CEO)
Tel: +972-3-608-6024
dudim@elbitimaging.com
Investor Contact:
Mor Dagan
Investor Relations
Tel: +972-3-516-7620
mor@km-ir.co.il
SOURCE Elbit Imaging Ltd.
